Company profile for Aeovian Pharmaceuticals

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

We are a San Francisco Bay Area-based research stage biopharmaceutical company aiming to discover, develop & commercialize innovative therapeutics for the treatment of rare & age-related diseases. We are developing compounds to modulate molecular pathways that address the underlying causes of disease initiation and progression, such as oxidative, cellular and environmental stress. Our lead compounds are novel & highly selectiv...
We are a San Francisco Bay Area-based research stage biopharmaceutical company aiming to discover, develop & commercialize innovative therapeutics for the treatment of rare & age-related diseases. We are developing compounds to modulate molecular pathways that address the underlying causes of disease initiation and progression, such as oxidative, cellular and environmental stress. Our lead compounds are novel & highly selective therapeutics that potently inhibit the mTORC1 pathway. Genetic mutations, aging result in abnormal activation of mTORC1; normalization of its aberrant activity.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
156 2nd St San Francisco, California
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/aeovian-pharmaceuticals-doses-first-participants-in-phase-1-clinical-trial-strengthens-leadership-team-and-raises-additional-50-million-financing-302101427.html

PR NEWSWIRE
28 Mar 2024

https://endpts.com/aeovian-pharmaceuticals-brings-in-37-million-in-mtor-play/

ENDPTS
03 Oct 2019

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty